GRINX
Price
$21.44
Change
+$0.20 (+0.94%)
Updated
Jun 6 closing price
Net Assets
324.73M
VITSX
Price
$143.69
Change
+$1.51 (+1.06%)
Updated
Jun 6 closing price
Net Assets
1.82T
Interact to see
Advertisement

GRINX vs VITSX

Header iconGRINX vs VITSX Comparison
Open Charts GRINX vs VITSXBanner chart's image
Victory Diversified Stock R
Price$21.44
Change+$0.20 (+0.94%)
VolumeN/A
Net Assets324.73M
Vanguard Total Stock Market Idx I
Price$143.69
Change+$1.51 (+1.06%)
VolumeN/A
Net Assets1.82T
GRINX vs VITSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GRINX vs. VITSX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GRINX is a Buy and VITSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VITSX has more cash in the bank: 1.82T vs. GRINX (325M). VITSX pays higher dividends than GRINX: VITSX (1.29) vs GRINX (0.00). GRINX was incepted earlier than VITSX: GRINX (26 years) vs VITSX (28 years). GRINX (1.36) is less costly to investors than VITSX (0.03). GRINX is a more actively managed with annual turnover of: 81.00 vs. VITSX (2.00). GRINX has a lower initial minimum investment than VITSX: GRINX (0) vs VITSX (5000000). VITSX annual gain was more profitable for investors over the last year : 10.97 vs. GRINX (2.31). VITSX return over 5 years is better than : 80.96 vs. GRINX (30.88).
GRINXVITSXGRINX / VITSX
Total Expense Ratio1.360.034,533%
Annual Report Gross Expense Ratio1.360.034,533%
Fund Existence26 years28 years-
Gain YTD2.2140.833266%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets325M1.82T0%
Annual Yield % from dividends0.001.29-
Returns for 1 year2.3110.9721%
Returns for 3 years9.1140.3523%
Returns for 5 years30.8880.9638%
Returns for 10 years6.43180.494%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FBTIX28.77N/A
N/A
Fidelity Advisor Biotechnology I
FEYIX27.80N/A
N/A
Fidelity Advisor Asset Manager 85% I
MNHRX25.79N/A
N/A
Manning & Napier Pro-Blend Max Term R
FWMNX17.06N/A
N/A
Fidelity Advisor Women's Leadership I
EEMHX8.78N/A
N/A
MFS Emerging Markets Equity Research R6